The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2019 | Dutch HOVON lymphoma study group update
Pieternella Lugtenburg
• 20 Jun 2019
Pieternella Lugtenburg, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands, discusses the current research of the Dutch HOVON lymphoma study group. She covers diffuse large B-cell lymphoma (DLBCL), double-hit lymphoma, and Burkitt’s lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
